1. Home
  2. RCKT vs KBSX Comparison

RCKT vs KBSX Comparison

Compare RCKT & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • KBSX
  • Stock Information
  • Founded
  • RCKT 1999
  • KBSX 1976
  • Country
  • RCKT United States
  • KBSX Taiwan
  • Employees
  • RCKT N/A
  • KBSX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • KBSX Recreational Games/Products/Toys
  • Sector
  • RCKT Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • RCKT 326.4M
  • KBSX 299.4M
  • IPO Year
  • RCKT N/A
  • KBSX N/A
  • Fundamental
  • Price
  • RCKT $2.48
  • KBSX $1.77
  • Analyst Decision
  • RCKT Buy
  • KBSX
  • Analyst Count
  • RCKT 13
  • KBSX 0
  • Target Price
  • RCKT $18.50
  • KBSX N/A
  • AVG Volume (30 Days)
  • RCKT 4.7M
  • KBSX 1.1M
  • Earning Date
  • RCKT 08-04-2025
  • KBSX 05-16-2025
  • Dividend Yield
  • RCKT N/A
  • KBSX N/A
  • EPS Growth
  • RCKT N/A
  • KBSX N/A
  • EPS
  • RCKT N/A
  • KBSX N/A
  • Revenue
  • RCKT N/A
  • KBSX $36,499,644.00
  • Revenue This Year
  • RCKT N/A
  • KBSX N/A
  • Revenue Next Year
  • RCKT N/A
  • KBSX N/A
  • P/E Ratio
  • RCKT N/A
  • KBSX N/A
  • Revenue Growth
  • RCKT N/A
  • KBSX 27.04
  • 52 Week Low
  • RCKT $2.19
  • KBSX $1.26
  • 52 Week High
  • RCKT $26.98
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 31.96
  • KBSX N/A
  • Support Level
  • RCKT $2.50
  • KBSX N/A
  • Resistance Level
  • RCKT $2.70
  • KBSX N/A
  • Average True Range (ATR)
  • RCKT 0.20
  • KBSX 0.00
  • MACD
  • RCKT 0.11
  • KBSX 0.00
  • Stochastic Oscillator
  • RCKT 4.82
  • KBSX 0.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high-performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: